Canada markets closed

ARCA biopharma, Inc. (ABIO)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
3.4000+0.1500 (+4.62%)
At close: 04:00PM EDT
3.2500 -0.15 (-4.41%)
After hours: 05:14PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 49.16M
Enterprise Value 11.93M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)1.33
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -1.66

Trading Information

Stock Price History

Beta (5Y Monthly) 1.21
52-Week Change 373.47%
S&P500 52-Week Change 320.07%
52 Week High 33.8800
52 Week Low 31.5600
50-Day Moving Average 32.0742
200-Day Moving Average 31.9423

Share Statistics

Avg Vol (3 month) 31.41M
Avg Vol (10 day) 3355.99k
Shares Outstanding 514.5M
Implied Shares Outstanding 614.5M
Float 85.68M
% Held by Insiders 11.29%
% Held by Institutions 171.80%
Shares Short (Mar 28, 2024) 4195.73k
Short Ratio (Mar 28, 2024) 47.31
Short % of Float (Mar 28, 2024) 41.89%
Short % of Shares Outstanding (Mar 28, 2024) 41.35%
Shares Short (prior month Feb 29, 2024) 4182.32k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Apr 04, 2019
Ex-Dividend Date 4N/A
Last Split Factor 21:18
Last Split Date 3Apr 04, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-11.02%
Return on Equity (ttm)-13.57%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
Net Income Avi to Common (ttm)-5.34M
Diluted EPS (ttm)-0.3700
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)37.43M
Total Cash Per Share (mrq)2.58
Total Debt (mrq)280k
Total Debt/Equity (mrq)0.76%
Current Ratio (mrq)59.01
Book Value Per Share (mrq)2.55

Cash Flow Statement

Operating Cash Flow (ttm)-5.01M
Levered Free Cash Flow (ttm)-4.14M